Quanterix (QTRX) Projected to Post Quarterly Earnings on Monday

Quanterix (NASDAQ:QTRX) is expected to be issuing its results before the market opens on Monday, December 22nd. Analysts expect the company to announce earnings of ($0.23) per share for the quarter.

Quanterix (NASDAQ:QTRX) last released its earnings results on Monday, November 10th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.13). The firm had revenue of $40.23 million for the quarter, compared to the consensus estimate of $37.85 million. Quanterix had a negative return on equity of 21.34% and a negative net margin of 73.47%. On average, analysts expect Quanterix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quanterix Price Performance

QTRX opened at $6.59 on Friday. The company has a 50 day simple moving average of $6.26 and a two-hundred day simple moving average of $5.78. The firm has a market cap of $307.82 million, a P/E ratio of -2.83 and a beta of 1.01. Quanterix has a 1-year low of $4.05 and a 1-year high of $12.41.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on QTRX shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quanterix in a research note on Wednesday, October 8th. Wall Street Zen lowered Quanterix from a “hold” rating to a “sell” rating in a research note on Sunday. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Quanterix presently has an average rating of “Hold” and a consensus price target of $10.33.

Institutional Trading of Quanterix

Large investors have recently added to or reduced their stakes in the company. Quarry LP raised its holdings in shares of Quanterix by 277,300.0% in the third quarter. Quarry LP now owns 5,548 shares of the company’s stock worth $30,000 after buying an additional 5,546 shares during the period. HUB Investment Partners LLC bought a new position in Quanterix in the 2nd quarter valued at $81,000. Jain Global LLC purchased a new stake in Quanterix in the third quarter worth $94,000. Brevan Howard Capital Management LP bought a new stake in shares of Quanterix during the second quarter worth $96,000. Finally, State of Wyoming lifted its position in shares of Quanterix by 105.3% during the second quarter. State of Wyoming now owns 14,814 shares of the company’s stock worth $99,000 after purchasing an additional 7,599 shares during the last quarter. Institutional investors own 86.48% of the company’s stock.

Quanterix Company Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.